Detection of Brain Metastasis With 68Ga-Labeled PSMA Ligand PET/CT A Novel Radiotracer for Imaging of Prostate Carcinoma

被引：47

作者：

Chakraborty, Partha Sarathi ^{[1
]}

Kumar, Rajiv ^{[1
]}

Tripathi, Madhavi ^{[1
]}

Das, Chandan Jyoti ^{[2
]}

Bal, Chandrasekhar ^{[1
]}

机构：

[1] All India Inst Med Sci, Dept Nucl Med & PET, New Delhi, India

[2] All India Inst Med Sci, Dept Radiodiag, New Delhi, India

来源：

CLINICAL NUCLEAR MEDICINE | 2015年 / 40卷 / 04期

关键词：

prostate cancer; cerebral metastases; Ga-68-PSMA; PET/CT; CANCER;

D O I：

10.1097/RLU.0000000000000709

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Brain metastasis in prostate cancer is rare and not expected at initial presentation especially when the patient is asymptomatic for the same. A 45-year-old male patient undergoing initial evaluation for newly diagnosed prostatic adenocarcinoma was referred to our department for Tc-99m-MDP bone scintigraphy. As part of the study protocol, he also underwent Glu-NH-CO-NH-Lys(Ahx)-[Ga-68(HBED-CC)] (Ga-68-PSMA) PET/CT, which revealed tracer accumulation in brain lesions, apart from localization in the primary, lymph node, and bone metastases. A subsequent MR evaluation confirmed brain metastases.

引用

页码：328 / 329

页数：2

共 9 条

[1] Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience [J].

Afshar-Oromieh, A. ;

Haberkorn, U. ;

Schlemmer, H. P. ;

Fenchel, M. ;

Eder, M. ;

Eisenhut, M. ;

Hadaschik, B. A. ;

Kopp-Schneider, A. ;

Roethke, M. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) :887-897

[2] PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions [J].

Afshar-Oromieh, A. ;

Malcher, A. ;

Eder, M. ;

Eisenhut, M. ;

Linhart, H. G. ;

Hadaschik, B. A. ;

Holland-Letz, T. ;

Giesel, F. L. ;

Kratochwil, C. ;

Haufe, S. ;

Haberkorn, U. ;

Zechmann, C. M. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) :486-495

[3] [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH [J].

Afshar-Oromieh, A. ;

Haberkorn, U. ;

Eder, M. ;

Eisenhut, M. ;

Zechmann, C. M. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (06) :1085-1086

[4] Technology Insight: monoclonal antibody imaging of prostate cancer [J].

Bander, NH .

NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (04) :216-225

[5] Imaging prostate cancer: An update on positron emission tomography and magnetic resonance imaging [J].

Bouchelouche K. ;

Turkbey B. ;

Choyke P. ;

Capala J. .

Current Urology Reports, 2010, 11 (3) :180-190

[6] Brain Metastases from Prostate Cancer: An 11-Year Analysis in the MRI Era with Emphasis on Imaging Characteristics, Incidence, and Prognosis [J].

Hatzoglou, Vaios ;

Patel, Gita V. ;

Morris, Michael J. ;

Curtis, Kristen ;

Zhang, Zhigang ;

Shi, Weiji ;

Huse, Jason ;

Rosenblum, Marc ;

Holodny, Andrei I. ;

Young, Robert J. .

JOURNAL OF NEUROIMAGING, 2014, 24 (02) :161-166

[7] Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis [J].

Mannweiler, Sebastian ;

Amersdorfer, Peter ;

Trajanoski, Slave ;

Terrett, Jonathan A. ;

King, David ;

Mehes, Gabor .

PATHOLOGY & ONCOLOGY RESEARCH, 2009, 15 (02) :167-172

[8] Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases [J].

Sweat, SD ;

Pacelli, A ;

Murphy, GP ;

Bostwick, DG .

UROLOGY, 1998, 52 (04) :637-640

[9] Brain metastasis from prostate carcinoma - The M. D. Anderson cancer center experience [J].

Tremont-Lukats, IW ;

Bobustuc, G ;

Lagos, GK ;

Lolas, K ;

Kyritsis, AP ;

Puduvalli, VK .

CANCER, 2003, 98 (02) :363-368

← 1 →